Calliditas Therapeutics AB Sponsored ADR Gross Margin 2020-2024 | CALT
Current and historical gross margin for Calliditas Therapeutics AB Sponsored ADR (CALT) over the last 10 years. The current gross profit margin for Calliditas Therapeutics AB Sponsored ADR as of June 30, 2024 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-06-30 | $0.15B | $0.14B | 94.00% |
| 2024-03-31 | $0.12B | $0.12B | 95.16% |
| 2023-12-31 | $0.11B | $0.11B | 94.74% |
| 2023-09-30 | $0.11B | $0.11B | 95.61% |
| 2023-06-30 | $0.11B | $0.11B | 95.54% |
| 2023-03-31 | $0.09B | $0.09B | 95.70% |
| 2022-12-31 | $0.08B | $0.08B | 96.25% |
| 2022-09-30 | $0.04B | $0.04B | 95.12% |
| 2022-06-30 | $0.04B | $0.04B | 97.44% |
| 2021-09-30 | $0.02B | $0.02B | 100.00% |
| 2020-12-31 | $0.00B | 0 | nan% |
| 2020-03-31 | $0.02B | $0.02B | 100.00% |
